Renal Denervation Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

Renal Denervation Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

Report Description
Renal denervation is a catheter-based minimally-invasive procedure. It is a therapy performed by radiofrequency or ultrasound ablation for uncontrolled hypertension. Renal denervation is performed through endovascular catheter-based procedure to treat hypertension, which is beyond medication control. The procedure consists of a catheter that emits radiofrequency energy across multiple electrodes. Radiofrequency pulse is applied to the renal artery, which causes the wall of artery to ablate, reducing the nerve activity, thereby reducing blood pressure. The progress of catheter-based interventional therapies has yielded impressive results in certifying enhanced blood pressure control in patients with complaints of uncontrolled hypertension, vascular, and cardiovascular diseases.
Market Dynamics
Increasing prevalence of hypertension is a major factor driving renal denervation device market growth. According to the World Health Organization (WHO), the prevalence of high blood pressure in adults aged 25 and above was around 40% in 2008 and number of people with uncontrolled hypertension increased from 600 million in 1980 to around 1 billion in 2008. According to Fourth National Family Health Survey hypertension led to 1.63 million deaths in India in 2016 as compared to 0.78 million in 1990 and hypertension increased from 21 million in 1990 to 39 million in 2016.
Moreover, effective treatment through minimally-invasive catheter-based endovascular procedure is also expected to be drive growth of the market. For instance in 2013, U.S. FDA approved Symplicity HTN-4 renal denervation device. The device offers targeted radiofrequency energy delivery and minimizes the potential threat to surrounding tissues.
Key features of the study:
This report provides in-depth analysis of the renal denervation devices market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global renal denervation devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include St. Jude Medical, Inc., ReCor Medical Inc., Boston Scientific Corporation, Cardiosonic Ltd, Medtronic Plc., Kona medical, Inc., Mercator Medsystems, Inc., Terumo Corporation, Abbott Laboratories, and Theragenics Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global renal denervation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the renal denervation devices market
Detailed Segmentation:
Global Renal Denervation Devices Market, By Product Type:
Simplicity Renal Denervation System
Vessix Renal denervation System
EnligHTN
Paradise Renal Denervation System
Iberis Renal Sympathetic Denervation System
Others
Global Renal Denervation Devices Market, By Technology:
Radiofrequency
Ultrasound
Global Renal Denervation Devices Market, By End User:
Hospitals
Ambulatory Surgical Centers
Others
Global Renal Denervation Devices Market, By Geography:
North America
By Product Type:
Simplicity Renal Denervation System
Vessix Renal denervation System
EnligHTN
Paradise Renal Denervation System
Iberis Renal Sympathetic Denervation System
Others
By Technology:
Radiofrequency
Ultrasound
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
U.S.
Canada
Latin America
By Product Type:
Simplicity Renal Denervation System
Vessix Renal denervation System
EnligHTN
Paradise Renal Denervation System
Iberis Renal Sympathetic Denervation System
Others
By Technology:
Radiofrequency
Ultrasound
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Simplicity Renal Denervation System
Vessix Renal denervation System
EnligHTN
Paradise Renal Denervation System
Iberis Renal sympathetic Denervation System
others
By Technology:
Radiofrequency
Ultrasound
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Simplicity Renal Denervation System
Vessix Renal denervation System
EnligHTN
Paradise Renal Denervation System
Iberis Renal sympathetic Denervation System
Others
By Technology:
Radiofrequency
Ultrasound
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Simplicity Renal Denervation System
Vessix Renal denervation System
EnligHTN
Paradise Renal Denervation System
Iberis Renal sympathetic Denervation System
Others
By Technology:
Radiofrequency
Ultrasound
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Simplicity Renal Denervation System
Vessix Renal denervation System
EnligHTN
Paradise Renal Denervation System
Iberis Renal sympathetic Denervation System
Others
By Technology:
Radiofrequency
Ultrasound
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
St. Jude Medical *
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
ReCor Medical Inc.
Boston Scientific Corporation
Cardiosonic Ltd
Medtronic Plc.
Kona medical, Inc.
Mercator Medsystems, Inc.
Terumo Corporation
Abbott Laboratories
Theragenics Corporation
“*” marked represents similar segmentation in other categories in the respective section.